| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Recruits the N-CoR/Histone Deacetylase 3 Corepressor to Regulate the Circadian Bmal1 Gene
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine and Department of Genetics, and The Institute for Diabetes, Obesity, and Metabolism University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
Address all correspondence and requests for reprints to: Mitchell A. Lazar, M.D., Ph.D., University of Pennsylvania School of Medicine, 611 CRB, 415 Curie Boulevard, Philadelphia, Pennsylvania19104-6149. E-mail: lazar{at}mail.med.upenn.edu
| ABSTRACT |
|---|
|
|
|---|
has recently been implicated as a major regulator of the circadian clock. Expression of Bmal1, the master regulator of circadian rhythm in mammals, is negatively correlated with Rev-erb
mRNA level, but the molecular mechanism underlying this regulation is largely unknown. Here we show that Rev-erb
dramatically represses the basal activity of the mouse Bmal1 gene promoter via two monomeric binding sites, both of which are required for repression and are conserved between mouse and human. Rev-erb
directly binds to the mouse Bmal1 promoter and recruits the endogenous nuclear receptor corepressor (N-CoR)/histone deacetylase 3 (HDAC3) complex, in association with a decrease in histone acetylation. The endogenous N-CoR/HDAC3 complex is also associated with the endogenous Bmal1 promoter in human HepG2 liver cells, where a reduction in cellular HDAC3 level markedly increases the expression of Bmal1 mRNA. These data demonstrate a new function for the N-CoR/HDAC3 complex in regulating the expression of genes involved in circadian rhythm by functioning as corepressor for Rev-erb
. | INTRODUCTION |
|---|
|
|
|---|
Circadian rhythms are generated and maintained by feedback loops involving the transcription and translation of core clock genes (1, 4, 5, 6, 7, 8). In mammals, the transcription factors CLOCK (circadian locomotor output cycles kaput) and BMAL1 [also called MOP3 (member of PAS super family 3)] form heterodimers that activate the expression of Per and Cry by binding to E-box elements within their promoters (1, 4, 7). The PER and CRY proteins then multimerize and translocate to the nucleus, where CRY proteins repress the transcriptional activity of the CLOCK-BMAL1 heterodimer (1, 4, 7). Human advanced sleep phase syndrome is associated with mutations in the Per2 gene, which affects the turnover rate of PER2 protein (9).
Recently, the orphan nuclear receptor Rev-erb
has emerged as a critical component of the core circadian feedback loop that control cyclic expression of the Bmal1 gene both in the SCN and in the peripheral clock liver (10, 11, 12). Rev-erb
is a unique nuclear receptor that lacks the activation function 2 domain that is required for ligand-dependent activation of transcription by other members of the nuclear receptor superfamily (13, 14). Therefore, Rev-erb
constitutively behaves as an unliganded receptor, repressing transcription by binding to corepressor molecules (13, 14, 15). Rev-erb
preferentially recruits the corepressor N-CoR (13, 15, 16, 17, 18), which brings with it a multiprotein complex that includes histone deacetylase 3 (HDAC3) (15, 19, 20). HDAC3 alters local chromatin structure by removing acetyl groups from histone and creating a chromatin structure that is not favorable for accessibility of the basal transcription machinery (19, 20).
Rev-erb
monomers bind to a highly specific DNA sequence consisting of the classic nuclear receptor half-site hexamer AGGTCA with AANT (where N is any nucleotide) as the 5' flanking sequence (13). The retinoid-related orphan receptor (ROR) binds to the same site, referred to as an RORE, and constitutively activates transcription as a monomer (21, 22, 23). Rev-erb
can inhibit transcription as a monomer by competing with ROR for their shared binding site (22, 24, 25). However, monomeric binding of Rev-erb
is insufficient for corepressor binding, which requires two Rev-erb
half-sites (13, 18). When two ROREs are present as a direct repeat separated by two bases the two Rev-erb
molecules bind cooperatively, but functional corepressor recruitment is also achieved when two monomeric binding sites are present in proximity to one another (18).
Rev-erb
is widely expressed, and its mRNA is induced during adipocyte differentiation (26). Several genes have been found to be repressed by Rev-erb
, including human ApoCIII gene (24), N-myc (27), and Rev-erb
itself (28), suggesting diverse functions of this nuclear receptor in vivo. The role of Rev-erb
in circadian biology involves the regulation of the Bmal1 gene expression (11, 12, 25). Loss of the Bmal1 gene in mice results in immediate and complete loss of circadian rhythmicity in constant darkness and impaired locomotor activity in light-dark cycles, suggesting the role of Bmal1 as a nonredundant and essential component of the circadian pacemaker in mammals (29, 30). Bmal1 mRNA displays a cyclic expression pattern (29), and this is disrupted in mice lacking Rev-erb
(11, 31). Compared with wild type, the Rev-erb
mutant mice displayed a sustained high level of Bmal1 expression (11). Rev-erb
mRNA is normally expressed in a phase opposite to the Bmal1 mRNA, suggesting a negative regulatory role, but the detailed mechanisms underlying this repression are unclear.
Here we show that the Rev-erb
directly binds to and represses the Bmal1 gene promoter via two ROREs, each of which is necessary for this effect. Using chromatin immunoprecipitation, we demonstrate that this process involves active recruitment of the N-CoR/HDAC3 complex, leading to histone deacetylation. In liver cells, the Bmal1 mRNA is induced by knockdown of this pathway, indicating that the endogenous gene is controlled by this mechanism. Thus, the ability of Rev-erb
to repress the Bmal1 gene depends upon recruitment of the N-CoR/HDAC3 complex, leading to histone modification of this critical circadian gene.
| RESULTS |
|---|
|
|
|---|
Represses the Basal Activity of the Mouse Bmal1 Promoter
/ROR monomer binding sites spaced by 26 bp have been identified in the proximal promoter region of the Bmal1 gene (11, 32). Because ROR is active as a monomer on such sites (25), we will refer to them as ROREs. Both the distal and proximal ROREs, here referred to as ROREd and ROREp, respectively, are highly conserved in mouse and human (Fig. 1A
has not been tested. We first determined whether Rev-erb
can repress the activity of the proximal Bmal1 promoter by using a reporter vector containing approximately 1 kb of the mouse Bmal1 promoter driving the luciferase gene. Cotransfection of Rev-erb
dramatically repressed the expression of this gene, but not the parent luciferase vector (Fig. 1B
(Fig. 1C
was observed in multiple cell types including 293T, Hela and NIH3T3 cells (Fig. 1D
|
Is Required for Repression of the Bmal1 Gene
might inhibit Bmal1 gene expression is via DNA binding competition with constitutively active ROR orphan receptors (25). This possibility was tested using a C-terminal truncated mutant [1236] that retains full DNA binding activity but lacks the corepressor interaction domain (13, 17). In contrast to full-length Rev-erb
(wild type), Rev-erb
[1236] failed to repress the promoter activity of Bmal1 (Fig. 2A
is necessary for repression of the Bmal1 promoter. Although it had no activity on its own, Rev-erb
[1236] dose-responsively abrogated repression due to full-length Rev-erb
(Fig. 2B
. This could be overcome by increasing concentrations of Rev-erb
(Fig. 2C
|
Binds to the Bmal1 Gene Promoter in Association with Cellular N-CoR/HDAC3
to bind and recruit active corepressor complexes to the Bmal1 promoter was determined using chromatin immunoprecipitation (ChIP) focusing on the region of the Bmal1 promoter that contained the putative Rev-erb
binding sites (Fig. 3A
, relatively little N-CoR/HDAC3 could be identified in association with this region of the Bmal1 promoter (Fig. 3B
was readily identified at the promoter, along with endogenous corepressor N-CoR silencing mediator for retinoids and thyroid hormone receptor (SMRT) (using an antibody that recognizes a common epitope) and associated HDAC3 (Fig. 3B
mediated recruitment of the HDAC-containing corepressor complex. To our knowledge, this is the first evidence demonstrating the potential role of endogenous N-CoR/HDAC3 complex in regulation of a circadian clock gene.
|

-mediated repression of gene expression from the Bmal1 promoter (Fig. 4A
(Fig. 4B
-mediated repression. ChIP analysis revealed that mutation of the ROREs dramatically impaired association of Rev-erb
with the Bmal1 promoter (Fig. 4C
is dependent on homodimer formation of Rev-erb
and that the repression process involves active recruitment of the nuclear receptor corepressor complex.
|
and Bmal1 genes are rhythmic and oppositely phased with respect to one another (11, 12, 34). We therefore investigated whether Rev-erb
represses the endogenous Bmal1 gene via the mechanism we have delineated for the transfected Bmal1 reporter. Endogenous Rev-erb
was detected at the Bmal1 promoter in human HepG2 liver cells (Fig. 5A
was HDAC3, the major component of the nuclear corepressor complex. Thus, the endogenous Bmal1 is targeted by Rev-erb
and the corepressor complex in liver cells.
|
. We therefore suspected that recruitment of HDAC3 to the endogenous Bmal1 promoter was critical for basal repression of this gene. To test this we used small interfering RNA (siRNA) to reduce the expression of HDAC3 in HepG2 cells (Fig. 5B| DISCUSSION |
|---|
|
|
|---|
has been suggested to regulate the expression of the clock gene Bmal1, but the molecular mechanism has not previously been explored. Here we have shown that Rev-erb
represses basal transcription of the Bmal1 gene by binding to two closely spaced monomeric ROREs, both of which are required for this repressive function. Binding of two Rev-erb
molecules leads to recruitment of the nuclear receptor corepressor-HDAC3 complex, which triggers histone deacetylation at the Bmal1 promoter. Consistent with this mechanism, we have demonstrated that endogenous HDAC3 actively represses the basal expression of the endogenous Bmal1 gene in liver cells.
BMAL1, along with its heterodimer partner CLOCK, are major positive components of the molecular circadian clock (7, 8, 29). BMAL1-CLOCK heterodimers activate transcription of negative clock components, including Rev-erb
itself as well as PER and CRY, leading to and propagating oscillatory gene expression (10, 30, 35, 36). Intriguingly, Bmal1 is the only positive clock component whose mRNA displays robust circadian oscillation in both the SCN and peripheral clocks (11, 12, 25). ROR
strongly activates the Bmal1 promoter in transient transfection assays (25), but its expression is normally constant (11). By contrast, the expression of Rev-erb
, the major negative regulator of Bmal1, is cyclical (11, 12). In absence of the Rev-erb
gene, hepatic Bmal1 gene expression remains at a nearly constant, high-level of expression (11).
Our results demonstrate that Rev-erb
is indeed recruited to the Bmal1 promoter, and this is mediated by binding to two closely spaced ROREs that allows Rev-erb
to actively repress basal transcription of the Bmal1 gene by recruiting the N-CoR/HDAC3 corepressor complex. Thus, although DNA binding by Rev-erb
competitively prevents ROR
from activating the Bmal1 promoter (25), the architecture of the gene favors active, enzymatically mediated repression of the Bmal1 gene. In support of this, our knockdown experiments have demonstrated a direct link between HDAC3 and the regulation of the endogenous Bmal1 gene. Modulation of this activity would be predicted to influence the circadian clock. Indeed, HDAC inhibitors have been shown to alter circadian rhythms (10, 37). Our data strongly suggest that Rev-erb
and its associated N-CoR/HDAC3 complex is one likely target of this intervention. To our knowledge, this is the first report addressing the potential function of corepressor complexes in regulating circadian rhythms. Manipulations that selectively affect corepressor function may be useful remedies for circadian phase shift.
| MATERIALS AND METHODS |
|---|
|
|
|---|
(wild type) and Rev-erb
(1236) were created using standard subcloning techniques. All plasmids were confirmed by automatic sequencing analysis.
Mammalian Cell Culture and Transfection
293T cells and HepG2 cells were maintained in DMEM (high glucose) supplemented with 10% fetal bovine serum, 1 mM sodium pyruvate and 1 mM nonessential amino acid (all from Invitrogen Life Technologies, Carlsbad, CA). Cells were grown at 37 C in 5% CO2. All transient transfection assays were performed using Lipofectamine 2000 (Invitrogen Life Technologies) according to the manufacturers instructions. For repression assay, cells were grown in 24-well plates and 0.05 µg of Bmal1-luciferase reporter, 0.4 µg of pCDNA or pCDNA-Flag-Rev-erb
expression vector, and 0.1 µg of ß-galactosidase expression vector were added to each well. At 24 h after transfection, a luciferase assay kit (Promega, Madison, WI) was used to determine relative levels of the luciferase gene product. Light units were normalized to the cotransfected ß-galactosidase expression plasmid. Fold repression was calculated as the activity of a given reporter after transfection with control expression vector divided by the activity of the same reporter in the presence of Rev-erb
expression vector.
ChIP Assay
A ChIP assay was performed according to the protocols of Upstate Biotechnology (Lake Placid, NY) with minor modifications (15). 293T cells growing in a 100-mm plate were transfected with 12 µg of either pcDNA or pcDNA-Flag-Rev-erb
construct expression vector and 1.5 µg of Bmal1-luc vector. After overnight incubation, cells were cross-linked with 1% formaldehyde for 10 min at room temperature in PBS. Cells were washed three times with PBS and then collected in ice-cold PBS with 1x protease inhibitor (Roche Molecular Biochemicals). Cell pellets were obtained by centrifugation at 1000 x g in PBS for 4 min and resuspended in 500 µl of hypotonic buffer [50 mM Tris-HCl (pH 8.0), 85 mM KCl, 0.5% Nonidet P-40] with protease inhibitor. After incubation on ice for 10 min, the cell lysates were centrifuged for 8 min at 2000 x g. The pellets were resuspended in 300 µl of sodium dodecyl sulfate (SDS)-containing sonication buffer [0.01% SDS, 10 mM EDTA, 50 mM Tris-HCl (pH 8.1)] with protease inhibitor and sonicated three times for 20 sec each time followed by centrifugation at 14,000 x g for 10 min. Supernatants were collected and diluted 5-fold with dilution buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl (pH 8.1), 167 mM NaCl] with protease inhibitor followed by preclearing with 2 µg of sheared salmon sperm DNA and protein A Sepharose [50 µl of a 50% slurry in 10 mM Tris-HCl (pH 8.1)-1 mM EDTA] for 2 h at 4 C. Immunoprecipitation with the following antibodies was performed at 4 C overnight: anti-Flag, anti-HDAC3, anti-N-CoR/SMRT, antiacetyl histone H3 and H4 (Upstate Biotechnology) and normal rabbit IgG and normal mouse Ig (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Immunoprecipitated complexes were collected with protein A Sepharose beads followed by sequential washes in low-salt wash buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 150 mM NaCl], high-salt wash buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 500 mM NaCl], LiCl wash buffer [0.25 M LiCl, 1% Nonidet P-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl (pH 8.1)], and Tris-EDTA buffer. Precipitates were eluted with elution buffer (1% SDS, 0.1 M NaHCO3), and 5 M NaCl was added to reverse cross-links at 65 C for 6 h. DNA fragments were purified with a PCR purification kit (QIAGEN, Valencia, CA). A total of 13 µl of purified sample was used in 2328 cycles of PCR using one pair of primers encompassing both ROREs region of mouse Bmal1 promoter. The primers used for PCR used in Fig. 3
are as follows: forward: 5'-ggattggtcggaaagtacgtt-3'; reverse: 5'-aggaaccagggcgtatctct-3'. The primers used for PCR used in Fig. 4
are as follows: forward: 5'-ttgggcacagcgattggtg-3'; reverse: 5'-taaacaggcacctccgtccc-3'. The ChIP assay in HepG2 cells was performed using the same protocol. However, the optimal sonication condition of HepG2 cells was 25 sec for 4 times at output 8. The rabbit anti-Rev-erb
antibody was raised against the peptide: GSLQVAMEDSSRVSPSK. The primers used to amplify RORE region of human Bmal1 promoter in HepG2 cells are as follows: forward: 5'-cgacatttagggaaggcaga-3'; reverse: 5'-tttcggcccttaaagtctca-3'.
siRNA Expression
The control siRNA (D-00122001) and HDAC3 SMARTpool siRNA (M-00349600) were both purchased from Dharmacon (Lafayette, CO). HepG2 cells were transfected with siRNA using Lipofectamine 2000 (Invitrogen Life Technologies) with some modifications. In brief, HepG2 cells were transected when they were about 3050% confluence. The siRNA oligonucleotides were diluted in Opti-MEM reduced serum (Invitrogen Life Technologies) and then mixed with Lipofectamine 2000 prediluted in OptiMEM. The transfection reactions were incubated for about 25 min. Meanwhile, the HepG2 cells were washed once with OptiMEM and covered with fresh OptiMEM. After incubation time, the transfection reaction was added into the HepG2 cells and incubated at 37 C for 12 h. About 2 ml of fresh growth medium were added back to transfected cells. The HepG2 cells were exposed to siRNA treatment for total 96 h and then subjected to either immunoblotting or quantitative RT-PCR.
Immunoblotting
The protein lysate was prepared in RIPA buffer [50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Triton X-100, 0.4% deoxycholate, 0.1% SDS]. About 20 µg of protein were separated by SDS-PAGE and transferred to polyvinylidene difluoride membranes. Blots were probed with primary antibodies in Tris-buffered saline containing 5% nonfat dry milk followed by horseradish peroxidase-conjugated antirabbit or antimouse antibody (Pierce, Rockford, IL) at 1:5,000 dilution. Blots were visualized by ECL (Amersham Biosciences, Piscataway, NJ) and the following antibodies and dilutions: anti-HDAC3 antibodies (ABCAM Inc., Cambridge, MA) at 1:2,000 and anti-Hsp90 (heat shock protein 90) antibody at 1:10,000 (Santa Cruz Biotechnology).
Quantitative RT-PCR
Total RNA was prepared using an RNeasy kit (QIAGEN). cDNA was synthesized from RNA treated with deoxyribonuclease followed by reverse transcription reaction (Invitrogen Life Technologies) according to manufacturers instructions. mRNA transcripts were quantified by SYBR GREEN PCR kit (Applied Biosystems), using a Prism 7900 thermal cycler and sequence detector (Applied Biosystems). The primers used in the real-time PCR were the following: hBmal1forward, 5'-tgtgggcgctcactgtgt-3'; reverse, 5'-ttctgcctgatcctgtcatctct-3'; glyceraldehyde-3-phosphate dehydrogenase (Gapdh)forward, 5'-gaaggtgaaggtcggagtc-3'; reverse, 5'-gaagatggtgatgggatttc-3'. Both pairs of primers were designed using Primer express software and the primer efficiencies were greater than 95%. All the reactions were performed in quadruplicate, and each threshold cycle (Ct) value was an average of the values obtained from each reaction. The
Ct values were determined by substracting the Gapdh Ct values from the Bmal1 Ct values. The fold change in expression of the Bmal1 in the HDAC3 siRNA-treated group relative to that in control siRNA-treated group was expressed as 2-
Ct, in which 
Ct equals difference between the
Ct value of HDAC3 siRNA-treated cells and the
Ct value of the control group, which was normalized to 1.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
First Published Online March 10, 2005
Abbreviations: ChIP, Chromatin immunoprecipitation; CLOCK, circadian locomotor output cycles kaput; Ct, threshold cycle; dRORE, distal RORE; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; HDAC3, histone deacetylase; N-CoR, nuclear receptor corepressor; pRORE, proximal RORE; ROR, retinoid-related orphan receptors; RORE, ROR binding element; SCN, suprachiasmatic nuclei; SDS, sodium dodecyl sulfate; siRNA, small interfering RNA.
Received for publication January 24, 2005. Accepted for publication February 28, 2005.
| REFERENCES |
|---|
|
|
|---|
controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110:251260[CrossRef][Medline]
. Mol Endocrinol 13:15501557
regulates the human apolipoprotein CIII promoter. J Biol Chem 277:2712027129
, an orphan receptor encoded on the opposite strand of the
-thyroid hormone receptor gene, during adipocyte differentiation. J Biol Chem 268:1626516269
and RVR, two orphan members of the superfamily of nuclear hormone receptors. Mol Cell Biol 17:18601867[Abstract]
responsive element located in the human Rev-erb
promoter mediates a repressing activity. Proc Natl Acad Sci USA 93:35533558NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
Q. J. Meng, A. McMaster, S. Beesley, W. Q. Lu, J. Gibbs, D. Parks, J. Collins, S. Farrow, R. Donn, D. Ray, et al. Ligand modulation of REV-ERB{alpha} function resets the peripheral circadian clock in a phasic manner J. Cell Sci., November 1, 2008; 121(21): 3629 - 3635. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Burris Nuclear Hormone Receptors for Heme: REV-ERB{alpha} and REV-ERB{beta} Are Ligand-Regulated Components of the Mammalian Clock Mol. Endocrinol., July 1, 2008; 22(7): 1509 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Onishi, S. Hanai, T. Ohno, Y. Hara, and N. Ishida Rhythmic SAF-A Binding Underlies Circadian Transcription of the Bmal1 Gene Mol. Cell. Biol., May 15, 2008; 28(10): 3477 - 3488. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang and M. A. Lazar Bifunctional Role of Rev-erb{alpha} in Adipocyte Differentiation Mol. Cell. Biol., April 1, 2008; 28(7): 2213 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin, N. Wu, J. C. Curtin, M. Qatanani, N. R. Szwergold, R. A. Reid, G. M. Waitt, D. J. Parks, K. H. Pearce, G. B. Wisely, et al. Rev-erb{alpha}, a Heme Sensor That Coordinates Metabolic and Circadian Pathways Science, December 14, 2007; 318(5857): 1786 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Villagra, N. Ulloa, X. Zhang, Z. Yuan, E. Sotomayor, and E. Seto Histone Deacetylase 3 Down-regulates Cholesterol Synthesis through Repression of Lanosterol Synthase Gene Expression J. Biol. Chem., December 7, 2007; 282(49): 35457 - 35470. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. I. J. Crawford, C. L. Hodgkinson, E. Ivanova, L. B. Logunova, G. J. Evans, S. Steinlechner, and A. S. I. Loudon Influence of torpor on cardiac expression of genes involved in the circadian clock and protein turnover in the Siberian hamster (Phodopus sungorus) Physiol Genomics, November 14, 2007; 31(3): 521 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kakizawa, S.-i. Nishio, G. Triqueneaux, S. Bertrand, J. Rambaud, and V. Laudet Two differentially active alternative promoters control the expression of the zebrafish orphan nuclear receptor gene Rev-erb{alpha} J. Mol. Endocrinol., May 1, 2007; 38(5): 555 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang, K. A. Lamia, and R. M. Evans Nuclear Receptors, Metabolism, and the Circadian Clock Cold Spring Harb Symp Quant Biol, January 1, 2007; 72(0): 387 - 394. [Abstract] [PDF] |
||||
![]() |
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al. International Union of Pharmacology. LXVI. Orphan Nuclear Receptors Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, L. Yin, and M. A. Lazar The Orphan Nuclear Receptor Rev-erb{alpha} Regulates Circadian Expression of Plasminogen Activator Inhibitor Type 1 J. Biol. Chem., November 10, 2006; 281(45): 33842 - 33848. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin, J. Wang, P. S. Klein, and M. A. Lazar Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science, February 17, 2006; 311(5763): 1002 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Young The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H1 - H16. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |